Vestal Point Capital’s Globus Medical GMED Stock Holding History

Vestal Point Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.6M	Sell	610,520 -664,480	-52%	-$59.6M	1.47%	24
2025 Q4	$111M	Buy	1,275,000 +25,000	+2%	+$1.9M	3.78%	6
2025 Q3	$71.6M	Buy	1,250,000 +750,000	+150%	+$43.2M	3.23%	8
2025 Q2	$29.5M	Buy	500,000 +300,000	+150%	+$19.4M	1.55%	22
2025 Q1	$14.6M	Sell	200,000 -125,000	-38%	-$10.3M	1.05%	33
2024 Q4	$26.9M	Buy	+325,000	New	+$25.6M	1.59%	26
2024 Q3	–	Sell	-900,000	Closed	-$61.6M	–	78
2024 Q2	$61.6M	Sell	900,000 -100,000	-10%	-$5.97M	4.6%	5
2024 Q1	$53.6M	Buy	1,000,000 +200,000	+25%	+$10.8M	4.44%	5
2023 Q4	$42.6M	Buy	+800,000	New	+$39M	4.52%	7

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vestal Point Capital's GMED Position: Q1 2026 in Review

Vestal Point Capital reduced its Globus Medical (GMED) stake by 52% in Q1 2026, selling an estimated $59.6M and leaving 610,520 shares worth $52.6M. The position accounts for 1.47% of the portfolio, ranked #24.

Vestal Point Capital first reported a position in GMED in Q4 2023 and has held it in 9 quarters since. The position peaked at $111M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Vestal Point Capital held 610,520 shares of Globus Medical worth $52.6M as of Q1 2026.
Vestal Point Capital sold 664,480 Globus Medical shares in Q1 2026, an estimated $59.6M.
Globus Medical made up 1.47% of Vestal Point Capital's portfolio in Q1 2026, its #24 holding.
Vestal Point Capital first reported a position in Globus Medical in Q4 2023 and has held it in 9 quarters since.
Vestal Point Capital's Globus Medical position peaked at $111M in Q4 2025.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.